AI-generated summary
The authors tested transcranial low-level laser therapy in mice after controlled cortical impact brain injury, using one or three daily treatments starting 4 hours after injury. They report better performance on neurological and water maze tests, lower caspase-3 expression in the lesion, and more neuroprogenitor cells in the hippocampus and subventricular zone. The authors suggest the treatment may reduce cell death and stimulate neurogenesis, though this is an animal study.
- Who or what was studied
- Mice with controlled cortical impact traumatic brain injury
- Wavelengths
- 810 nm
- Limits stated in the abstract
- The study was conducted in mice, so findings may not apply to humans.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on spiedigitallibrary.org.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Traumatic brain injury, Laser, Low-level laser therapy, Brain injury, Stroke. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.